miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity Through PTEN and TIMP3 Downregulation

Cancer Cell- United States

doi 10.1016/j.ccr.2009.10.014

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer

PLoS ONE
Multidisciplinary
2014English

miR-221/222 Promote Malignant Progression of Glioma Through Activation of the Akt Pathway

International Journal of Oncology
Cancer ResearchOncology
2010English

Gastric Carcinogenesis in the miR-222/221 Transgenic Mouse Model

Cancer Research and Treatment
Cancer ResearchOncology
2017English

Bone Marrow Microenvironment Niche Regulates miR-221/222 in Acute Lymphoblastic Leukemia

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2016English

MicroRNA-222 (miR-222); miR-181b

Science-Business eXchange
2011English

Anti-microRNA-222 (Anti-miR-222) and -181b Suppress Growth of Tamoxifen-Resistant Xenografts in Mouse by Targeting TIMP3 Protein and Modulating Mitogenic Signal

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2011English

Overexpression of miR‑221 and miR‑222 in the Cancer Stroma Is Associated With Malignant Potential in Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Clustered microRNAs Hsa-miR-221-3p/Hsa-miR-222-3p and Their Targeted Genes Might Be Prognostic Predictors for Hepatocellular Carcinoma

Journal of Cancer
Oncology
2019English

Chrysin Overcomes TRAIL Resistance of Cancer Cells Through McL-1 Downregulation by Inhibiting STAT3 Phosphorylation

International Journal of Oncology
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy